Actively Recruiting
Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation
Led by Alain Kaelin · Updated on 2024-09-05
40
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
Sponsors
A
Alain Kaelin
Lead Sponsor
U
University of Applied Sciences and Arts of Southern Switzerland
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn about the WPM-SEMG-V2 device (Wireless Portable and Multi-Channel, WPM) designated to acquire high-density (HD) surface electromyography (sEMG) signals in healthy volunteers and post-stroke patients. The main objectives are: 1) to technically and clinically validate the WPM-SEMG-V2 device in healthy volunteers; 2) to demonstrate the clinical relevance of the HD sEMG signals to support the process of rehabilitation of post-stroke patients. Participants will be asked to perform simple exercises using the muscles of the hand or the leg in static or dynamic contractions while wearing the WPM-SEMG-V2 device.
CONDITIONS
Official Title
Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- Female or male
- At least 18 years old
- Ability to understand the investigation
- Willingness to complete all investigation assessments
- Ability to perform all investigation procedures
- Ability to perform maximal voluntary muscle extension of the target muscle and limb
- For healthy volunteers: recreationally active (at least 150 minutes of moderate activity weekly for the last six months), preferably between 18 and 20 years
- For post-stroke patients: first-time stroke
- Preserved cognitive capacity to perform the tasks
You will not qualify if you...
- Significant acute disease state
- Skin disorders or allergies at the contact site with the investigational device
- History of skin disease
- Known hypersensitivity or allergy to device components or materials (e.g., metal alloys, abrasive gel, foam with polystyrene markers)
- Chronic use of medications or treatment (for healthy volunteers)
- History of spinal cord injury or traumatic brain damage (for post-stroke patients)
- Serious medical illness preventing task performance
- Severe locomotion disorder due to other causes
- Severe neurological disease other than stroke
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto di Neuroscienze Cliniche della Svizzera Italiana
Lugano, Switzerland
Actively Recruiting
Research Team
A
Alain Kaelin, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here